The New York City Department of Health and Mental Hygiene reported a new case of serogroup C invasive meningococcal disease ( serogroup C Neisseria meningitidis) in an HIV infected man who has sex with men (MSM) in late June, according to a Health Alert late last week.
Image/CDC
This is the first case related to the 2012-2013 IMD outbreak since February 2013.
The patient had evidence of both meningitis and bacteremia and survived the illness. During the outbreak, 5 (42%) of 12 HIV-infected MSM died from meningococcal infection. The patient received two doses of meningococcal vaccine: the first dose in the fall of 2013 and the second in early 2014.
The Health Department continues to recommend meningococcal vaccine for the following New York City residents:
• All HIV-infected MSM
• MSM, regardless of HIV status, who regularly have close or intimate contact with other men met
either through an online website, digital application (“app”), or at a bar or party
The Health Department estimates that approximately 20%-25% of individuals recommended to receive meningococcal vaccine have received at least one dose. Providers should continue to offer vaccine to eligible patients who have not yet been vaccinated. For more infectious disease news and information, visit and “like” the Infectious Disease News Facebook page
One thought on “NYC reports first serogroup C invasive meningococcal disease in MSM in 17 months”